Frequency of Abnormal Biphasic aPTT Clot Waveforms in Patients with Underlying Disorders Associated with Disseminated Intravascular Coagulation

Abstract

Abnormal biphasic waveform (BPW) patterns were previously reported when the activated partial thromboplastin time (aPTT) was performed in plasma from patients with disseminated intravascular coagulation (DIC). In this study, the prevalence of the BPW was examined in a cohort of 508 hospitalized patients with elevated fibrinogen degradation products (FDP) levels (>10 μg/mL). The presence of a BPW was automatically flagged by the MDA® analyzer when the slope of the precoagulation phase in the waveform exceeded a threshold value of -0.25%T/sec. In our cohort, 76 patients (15%) were diagnosed with overt DIC according to the criteria recently proposed by the International Society of Thrombosis and Haemostasis (ISTH), whereas 96 patients (18.9%) were diagnosed with DIC following the criteria of the Japanese Ministry of Health and Welfare (JMHW). The JMHW and ISTH criteria agreed in 93% of cases (kappa coefficient 0.76). The concordance between both scoring systems was high in patients with infection but low in solid cancer. The BPW appeared in 65 patients (12.8%), with the highest prevalence (23.6%) in patients with infection. The BPW was more prevalent in the subgroup of patients with DIC: 59.2% and 47.9% for DIC diagnosed by ISTH and JMWH scores, respectively. The prevalence of the BPW was particularly high in patients with DIC and infection: 86.4% and 75.0% for DIC diagnosed by ISTH and JMWH scores, respectively. For the total cohort, the presence of the BPW was significantly associated with DIC. Odds ratios were 29.9 and 19.0 for ISTH and JMWH scores, respectively (p<0.0001). The BPW showed a moderate sensitivity (59.2% for the ISTH score; 47.9% for the JMWH score), but a high specificity (95.4% for both scores). Waveform analysis of the aPTT potentially provides a practical tool in risk assessment of critical care patients, in whom development of DIC is known to worsen the prognosis.

Keywords

Biphasic aPTT DIC Infection

References

Ten Cate HH , Timmerman JJ , Levi M. The pathophysiology of disseminated intravascular coagulation. Thromb Haemost 1999;82:713-713.

Levi M , de Jonge E , van der Poll T , ten Cate H. Disseminated intravascular coagulation. Thromb Haemost 1999;82:695-695.

Müller-Berghaus G , ten Cate H , Levi M. Disseminated intravascular coagulation: Clinical spectrum and established as well as new diagnostic approaches. Thromb Haemost 2001;86:1327-1327.

Taylor FB Jr , Toh CH , Hoots WK , et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. On behalf of the Scientific Subcommittee on disseminated intravascular coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Thromb Haemost 2001;86:1327-1327.

Warren BL , Eid A , Singer P , et al , and the KyberSept Trial Study Group . High-dose antithrombin in severe sepsis. A randomized controlled trial. JAMA 2001;286:1869-1869.

Bernard GR , Vincent JL , Laterre PF , et al. Efficacy and safety of recombinant human protein C for severe sepsis. N Engl J Med 2001;344:699-699.

Abraham E , Reinhart K , Opal S , et al , and the OPTIMIST Trial Study Group . Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: A randomized controlled trial. JAMA 2003;290:238-238.

Poller L. Activated partial thromboplastin time (APTT). In: Jespersen J , Bertina RM , Haverkate F , eds. Laboratory Techniques in Thrombosis—A Manual. ECAT Assay Procedures. Dordrecht, The Netherlands: Kluwer Academic Publishers, 1999:37-37.

Heins M , Renauer H. Automation in coagulation testing. JIFCC 1996;8:117-117.

10.

Braun PJ , Givens TB , Stead AG , et al. Properties of optical data from activated partial thromboplastin time and prothrombin time assays. Thromb Haemost 1007;78:1079-1079.

11.

Downey C , Kazmi R , Toh CH. Novel and diagnostically applicable information from optical waveform analysis of blood coagulation in disseminated intravascular coagulation. Br J Haematol 1997;98:68-68.

12.

Downey C , Kazmi R , Toh CH. Early identification and prognostic implications in disseminated intravascular coagulation through transmittance waveform analysis. Thromb Haemost 1998;80:65-65.

13.

Toh CH , Samis J , Downey C , et al. Biphasic transmittance waveform in the APTT coagulation assay is due to the formation of a Ca++-dependent complex of C-reactive protein with very low density lipoprotein and is a novel marker of impending disseminated intravascular coagulation. Blood 2002;100:2522-2522.

14.

Toh CH , Ticknor LO , Downey C , et al. Early identification of sepsis and mortality risks through simple, rapid clot-waveform analysis. Implications of lipoprotein-complexed C reactive protein formation. Intensive Care Med 2003; 29:55-55.

15.

Dempfle CE , Lorenz S , Smolinski M , et al. Utility of activated partial thromboplastin time waveform analysis for identification of sepsis and disseminated intravascular coagulation in patients admitted to a surgical intensive care unit. Crit Care Med 2004;32:520-520.

16.

Kobayashi N , Maegawa T , Takada M , et al. Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DIC in Japan. Bibl Haemotol 1983;49:265-265.

17.

Wada H , Gabazza EC , Asakura H , et al. Comparison of diagnostic criteria for disseminated intravascular coagulation (DIC): Diagnostic criteria of the International Society of Thrombosis and Haemostasis (ISTH) and of the Japanese Ministry of Health and Welfare for overt DIC. Am J Hematol 2003;74:17-17.

18.

Wada H , Wakita Y , Nakase T , et al. Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Thromb Haemost 1995; 74:848-848.

19.

Dennis MW , Downey C , Brufatto N , et al. Prothrombinase enhancement through quantitative and qualitative changes affecting very low density lipoprotein in complex with C-reactive protein. Thromb Haemost 2004;91:522-522.

20.

Wada H , Wakita Y , Nakase T , et al. Increased plasma soluble fibrin monomer levels in patients with disseminated intravascular coagulation. Am J Hematol 1996;51:255-255.